RT Journal Article
SR Electronic
T1 Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.20.20072223
DO 10.1101/2020.04.20.20072223
A1 Bello-Chavolla, Omar Yaxmehen
A1 Bahena-López, Jessica Paola
A1 Antonio-Villa, Neftali Eduardo
A1 Vargas-Vázquez, Arsenio
A1 González-Díaz, Armando
A1 Márquez-Salinas, Alejandro
A1 Fermín-Martínez, Carlos A.
A1 Naveja, J. Jesús
A1 Aguilar-Salinas, Carlos A.
YR 2020
UL http://medrxiv.org/content/early/2020/05/05/2020.04.20.20072223.abstract
AB BACKGROUND The SARS-CoV-2 outbreak poses challenge to healthcare systems due to high complication rates in patients with cardiometabolic diseases. Here, we identify risk factors and propose a clinical score to predict COVID-19 lethality, including specific factors for diabetes and obesity and its role in improving risk prediction.METHODS We obtained data of confirmed and negative COVID-19 cases and their demographic and health characteristics from the General Directorate of Epidemiology of Mexican Ministry of Health. We investigated specific risk factors associated to COVID-19 positivity and mortality and explored the impact of diabetes and obesity on modifying COVID-19 related lethality. Finally, we built a clinical score to predict COVID-19 lethality.RESULTS Among 71,103 subjects at April 27th, 2020, we observed 15,529 subjects with SARS-CoV-2 and 1,434 deaths. Risk factors for lethality in COVID-19 includes early-onset diabetes obesity, COPD, advanced age, immunosuppression, and CKD; we observed that obesity mediates 45.5% of the effect of diabetes on COVID-19 lethality. Early-onset diabetes conferred an increased risk of hospitalization and obesity conferred an increased risk for ICU admission and intubation. Our predictive score for COVID-19 lethality included age ≥65 years, diabetes, early-onset diabetes, obesity, age <40 years, CKD, hypertension, pregnancy and immunosuppression and significantly discriminates lethal from non-lethal COVID-19 cases (c-statistic=0.830).CONCLUSIONS Here, we propose a mechanistic approach to evaluate risk for complications and lethality attributable to COVID-19 considering the effect of obesity and diabetes in Mexico. Our score offers a clinical tool for quick determination of high-risk susceptibility patients in a first contact scenario.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data sources and R code are available for reproducibility of results at https://github.com/oyaxbell/covid_diabetesmx. https://github.com/oyaxbell/covid_diabetesmx